TAX PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I BINDS TO THE ANKYRIN MOTIFS OF INHIBITORY FACTOR KAPPA-B AND INDUCES NUCLEAR TRANSLOCATION OF TRANSCRIPTION FACTOR NF-KAPPA-B PROTEINS FOR TRANSCRIPTIONAL ACTIVATION
H. Hirai et al., TAX PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I BINDS TO THE ANKYRIN MOTIFS OF INHIBITORY FACTOR KAPPA-B AND INDUCES NUCLEAR TRANSLOCATION OF TRANSCRIPTION FACTOR NF-KAPPA-B PROTEINS FOR TRANSCRIPTIONAL ACTIVATION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 3584-3588
Human T-cell leukemia virus type I causes adult T-cell leukemia and tr
opical spastic paraparesis, and its regulator protein Tax has been imp
licated in the pathogenic activity of human T-cell leukemia virus type
I. Tax activates transcription of viral and cellular genes through sp
ecific enhancers: the 21-bp enhancer of human T-cell leukemia virus ty
pe I, the nuclear factor kappa B (NF-kappa B)-binding site of the inte
rleukin 2 receptor alpha gene, and the serum-responsive element of c-f
os. Tax binds to enhancer-binding proteins including cAMP-responsive e
lement-binding protein, cAMP-responsive element modulator, transcripti
on factor NF-kappa B p50 and p67(SRF), and associates with each enhanc
er DNA indirectly. In addition to this mechanism, we report here that
Tax binds to inhibitory factor kappa B gamma (I-kappa B) gamma, which
forms a complex with NF-kappa B protein heterodimer p50-p65 or homodim
er p50-p50 and retains them in the cytoplasm. Tax binding to I-kappa B
gamma induces nuclear translocation of NF-kappa B p65. In association
with this nuclear translocation of p65, transcription directed by the
kappa B enhancer is strongly activated. Tax binds to the ankyrin moti
fs of I-kappa B gamma, suggesting its possible interaction with many o
ther proteins carrying ankyrin moths contributing to various regulator
y processes. This is a different mechanism of transcriptional activati
on by the oncoprotein Tax and seems to be independent from the trans-a
ctivation through indirect binding to enhancer DNAs.